Table 1.
No. of exercise sessions n (%) | % of exercise sessions with CGM <70 mg/dL | |
---|---|---|
Overall | 8,827 (100%) | 8% |
Age | ||
18 − 29 years | 3266 (37%) | 8% |
30 − 39 years | 1992 (23%) | 8% |
40 − 49 years | 1503 (17%) | 7% |
≥50 years | 2066 (23%) | 10% |
Sex | ||
Female | 6470 (73%) | 8% |
Male | 2357 (27%) | 10% |
HbA1c | ||
≤6.0% | 1732 (20%) | 10% |
6.1%−6.4% | 2182 (25%) | 9% |
6.5%−6.9% | 2315 (26%) | 7% |
≥7.0% | 2598 (29%) | 8% |
T1D duration | ||
<10 years | 2416 (27%) | 6% |
10−<20 years | 3408 (39%) | 9% |
≥20 years | 3003 (34%) | 9% |
BMI | ||
Underweight (<18.5 kg/m2) | 18 (<1%) | 11% |
Normal (18.5−<25.0 kg/m2) | 5014 (57%) | 8% |
Overweight (25.0−<30.0 kg/m2) | 2780 (31%) | 9% |
Obese (≥30.0 kg/m2) | 1015 (11%) | 8% |
Insulin modality | ||
MDI | 1567 (18%) | 7% |
Pump | 3229 (37%) | 10% |
Hybrid closed-loop | 4031 (46%) | 8% |
IPAQ MET-minutes per week | ||
<1500 MET | 2503 (28%) | 6% |
1500−<3000 MET | 3017 (34%) | 8% |
≥3000 MET | 3307 (37%) | 10% |
PSQI hours asleep | ||
<7.5 h | 1414 (16%) | 10% |
7.5−<8.5 h | 3517 (40%) | 9% |
≥8.5 h | 3896 (44%) | 8% |
BMI, body mass index; CGM, continuous glucose monitoring; HbA1c, glycated hemoglobin A1c; IPAQ, International Physical Activity Questionnaire; MDI, multiple daily injections; MET, metabolic equivalent; PSQI, Pittsburgh Sleep Quality Index; T1D, type 1 diabetes.